CVS Health Co. (NYSE:CVS - Get Free Report) dropped 0.1% on Wednesday . The company traded as low as $52.34 and last traded at $53.08. Approximately 2,169,597 shares changed hands during mid-day trading, a decline of 84% from the average daily volume of 13,347,702 shares. The stock had previously closed at $53.15.
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on CVS. Deutsche Bank Aktiengesellschaft raised CVS Health from a "hold" rating to a "buy" rating and set a $66.00 target price for the company in a research report on Tuesday, December 3rd. Royal Bank of Canada dropped their price objective on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a research note on Friday, November 15th. TD Cowen raised their price objective on CVS Health from $73.00 to $80.00 and gave the stock a "buy" rating in a report on Monday, November 25th. UBS Group boosted their price objective on CVS Health from $60.00 to $62.00 and gave the stock a "neutral" rating in a research note on Thursday, November 7th. Finally, Truist Financial dropped their target price on CVS Health from $67.00 to $60.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, CVS Health has an average rating of "Moderate Buy" and an average price target of $68.71.
View Our Latest Stock Report on CVS
CVS Health Stock Performance
The business has a 50 day moving average price of $51.26 and a 200 day moving average price of $56.26. The stock has a market capitalization of $67.22 billion, a PE ratio of 13.54, a PEG ratio of 0.79 and a beta of 0.59. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.
CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts' consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. During the same period in the prior year, the business posted $2.21 earnings per share. The company's revenue was up 6.3% on a year-over-year basis. As a group, equities research analysts expect that CVS Health Co. will post 5.22 earnings per share for the current year.
CVS Health Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be paid a dividend of $0.665 per share. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.98%. CVS Health's dividend payout ratio is currently 67.51%.
Institutional Trading of CVS Health
Several large investors have recently bought and sold shares of CVS. Sound Income Strategies LLC lifted its holdings in CVS Health by 7.2% during the third quarter. Sound Income Strategies LLC now owns 2,397 shares of the pharmacy operator's stock valued at $151,000 after purchasing an additional 162 shares in the last quarter. Hexagon Capital Partners LLC grew its holdings in shares of CVS Health by 3.5% in the third quarter. Hexagon Capital Partners LLC now owns 5,268 shares of the pharmacy operator's stock valued at $331,000 after purchasing an additional 178 shares during the period. Bruce G. Allen Investments LLC increased its holdings in shares of CVS Health by 13.1% during the 3rd quarter. Bruce G. Allen Investments LLC now owns 1,681 shares of the pharmacy operator's stock worth $106,000 after buying an additional 195 shares during the last quarter. Integrated Advisors Network LLC grew its position in CVS Health by 0.7% in the third quarter. Integrated Advisors Network LLC now owns 27,625 shares of the pharmacy operator's stock worth $1,737,000 after acquiring an additional 200 shares during the period. Finally, Widmann Financial Services Inc. lifted its stake in shares of CVS Health by 1.8% in the 3rd quarter. Widmann Financial Services Inc. now owns 11,506 shares of the pharmacy operator's stock valued at $724,000 after purchasing an additional 200 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company's stock.
CVS Health Company Profile
(
Get Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
